INIS
women
100%
patients
47%
surgery
44%
ablation
37%
reviews
35%
pain
21%
comparative evaluations
19%
risks
17%
symptoms
16%
hospitals
15%
quality of life
14%
netherlands
14%
assessments
14%
removal
12%
devices
12%
organs
12%
blood
12%
cost
11%
interventions
11%
cancer
11%
data
10%
sampling
9%
diseases
9%
management
9%
oils
9%
losses
9%
surveys
8%
design
8%
failures
7%
pathology
7%
Medicine and Dentistry
Randomized Controlled Trial
50%
Endometrial Ablation
33%
Menorrhagia
32%
Systematic Review
30%
Hysterectomy
25%
Bleeding
24%
Levonorgestrel
22%
Meta-Analysis
14%
Surgery
14%
Pelvic Organ Prolapse
13%
Quality of Life
12%
Uterine Cancer
11%
Cohort Analysis
11%
Hysteroscopy
11%
Hysterosalpingography
10%
Endometriosis
9%
Cost-Effectiveness Analysis
9%
Laparoscopic Surgery
9%
Vaginal Vault Prolapse
8%
Uterine Myomectomy
8%
Sacrocolpopexy
8%
Patient Satisfaction
7%
Recurrent Disease
7%
Health Care Cost
6%
Diagnosis
6%
Spotting
6%
Prospective Cohort Study
6%
Drug Therapy
5%
Outpatient
5%
Vaginal Ultrasonography
5%
Keyphrases
Abnormal Uterine Bleeding
40%
Randomized Controlled Trial
38%
Endometrial Ablation
33%
Levonorgestrel-releasing Intrauterine System (LNG-IUS)
22%
Hysterectomy
16%
Meta-analysis
16%
Systematic Meta-analysis
15%
Multicenter Randomized Controlled Trial
15%
Netherlands
14%
Endometriosis
12%
Laparoscopic Sacrocolpopexy
10%
Hysterosalpingography
10%
Endometrial Cancer
9%
Hysteroscopy
9%
Confidence Interval
9%
Pelvic Organ Prolapse
9%
Uterine Prolapse
8%
After Surgery
8%
Transvaginal Hydrolaparoscopy
8%
Oil-based Contrast
8%
Laparoscopic Hysterectomy
7%
Dutch
7%
Postmenopausal Bleeding
7%
Quality of Life
7%
Laparoscopic Myomectomy
7%
Cost-effectiveness
7%
Infertile Women
7%
Essure
6%
Tubal Flushing
6%
Endometrial Sampling
6%